Pharmaceutical Giant Faces Market Crosscurrents as Regulatory Wins Clash with Pricing Pressures
Novo Nordisk shares experienced significant volatility during Thursday's trading session as conflicting forces buffeted the Danish pharmaceutical leader. While regulatory...













